StevenT.HarrisMDF.A.C.P.

PubMed

• 15 citations
  History of etidronate
  Nelson B. Watts, Charles H. Chesnut, Harry K. Genant, Steven T. Harris, Rebecca D. Jackson, Angelo A. Licata, Paul D. Miller, W. Jerry Mysiw, Bradford J. Richmond, Dav...> ;Bone. 2020 May 1
• 10 citations
  Western Osteoporosis Alliance Clinical Practice Series: Treat-to-Target for Osteoporosis.
  E. Michael Lewiecki, David L. Kendler, K. Shawn Davison, David A. Hanley, Steven T. Harris, Michael R. McClung, Paul D. Miller> ;The American Journal of Medicine. 2019 May 29
• 12 citations
  Proceedings of the 2017 Santa Fe Bone Symposium: Insights and Emerging Concepts in the Management of Osteoporosis
  E. Michael Lewiecki, John P. Bilezikian, John J. Carey, Richard M. Dell, Catherine M. Gordon, Steven T. Harris, Michael R. McClung, Paul D. Miller, Michael Rosenblatt> ;Journal of Clinical Densitometry. 2018 Jan 1
• 12 citations
  Diagnosis and Treatment of Osteoporosis Before and After Fracture: A Side-by-Side Analysis of Commercially Insured and Medicare Advantage Osteoporosis Patients
  Jessica Weaver, Shiva Sajjan, E. Michael Lewiecki, Steven T. Harris> ;Journal of Managed Care & Specialty Pharmacy. 2017 Jun 26
• 16 citations
  Western Osteoporosis Alliance Clinical Practice Series: Evaluating the Balance of Benefits and Risks of Long-Term Osteoporosis Therapies.
  David A. Hanley, Michael R. McClung, K. Shawn Davison, Larry Dian, S. T. Harris, Paul D. Miller, E. Michael Lewiecki, David L. Kendler> ;The American Journal of Medicine. 2017 Jul 1
• 43 citations
  Prevalence and Cost of Subsequent Fractures Among U.S. Patients with an Incident Fracture.
  Jessica Weaver, Shiva Sajjan, E. Michael Lewiecki, Steven T. Harris, Panagiotis Marvos> ;Journal of Managed Care & Specialty Pharmacy. 2017 Mar 25
• 31 citations
  Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years
  Ankita Modi, Shiva Sajjan, R Insinga, Jessica Weaver, E. M. Lewiecki, S. T. Harris> ;Osteoporosis International. 2017 Jan 5
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL ...
  Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST, Hurley DL, Kleerekoper M, Lewiecki EM, Miller PD, Narula HS, Pessah-Pollack R, Tangpricha V, Wimalawansa SJ, Wat...> ;Endocr Pract. 2016-09-02
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL ...
  Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST, Hurley DL, Kleerekoper M, Lewiecki EM, Miller PD, Narula HS, Pessah-Pollack R, Tangpricha V, Wimalawansa SJ, Wat...> ;Endocr Pract. 2016-09-01
• 5 citations
  Relationship Between Gastrointestinal Events and Compliance With Osteoporosis Therapy: An Administrative Claims Analysis of the US Managed Care Population.
  Ankita Modi, Shiva Sajjan, E. Michael Lewiecki, Steven T. Harris, Jessica Weaver> ;Clinical Therapeutics. 2016 May 1
• 175 citations
  Vertebral Fractures: Clinical Importance and Management
  David L. Kendler, Douglas C. Bauer, K. S. Davison, Larry Dian, David A. Hanley, S. T. Harris, Michael R. McClung, Paul D. Miller, John T. Schousboe, Chui K. Yuen, E. M...> ;The American Journal of Medicine. 2016 Feb 1
• 12 citations
  Understanding and communicating the benefits and risks of denosumab, raloxifene, and teriparatide for the treatment of osteoporosis.
  E. Michael Lewiecki, Paul D. Miller, S. T. Harris, Douglas C. Bauer, K. Shawn Davison, Larry Dian, David A. Hanley, Michael R. McClung, Chui K. Yuen, David L. Kendler> ;Journal of Clinical Densitometry. 2014 Oct 1
• 361 citations
  The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group
  Ethel S. Siris, Robert A. Adler, J. P. Bilezikian, M. A. Bolognese, Bess Dawson-Hughes, Murray J. Favus, S. T. Harris, S. M. Jan De Beur, Sundeep Khosla, Nancy E Lane,...> ;Osteoporosis International. 2014 Feb 28
• Medicines and bone loss.
  Bollerslev J, Harris ST, Leder BZ> ;J. Clin. Endocrinol. Metab.. 2013-04-01
• 10 citations
  Before the breaking point: reducing the risk of osteoporotic fracture.
  David A. Forstein, Catherine Bernardini, Raymond E Cole, Steven T. Harris, Andrea Singer> ;The Journal of the American Osteopathic Association. 2013 Feb 1
• 312 citations
  Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday
  Michael R. McClung, Steven T. Harris, Paul D. Miller, Douglas C. Bauer, K. Shawn Davison, Larry Dian, David A. Hanley, David L. Kendler, Chui Kin Yuen, E. Michael Lewi...> ;The American Journal of Medicine. 2013 Jan 1
• Osteoporosis inducida por glucocorticoides.
  Bollerslev, J., Harris, S.T., Leder, B.Z.> ;J Clin Endocrinol Metab. 2012-02-01
• Glucocorticoid-induced osteoporosis.
  Bollerslev, J., Harris, S.T., Leder, B.Z.> ;J Clin Endocrinol Metab. 2012 Feb
• Bisphosphonates for osteoporosis: benefits and risks.
  Bollerslev, J., Harris, S.T., Leder, B.Z.> ;J Clin Endocrinol Metab. 2011 Sep
• 51 citations
  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive su...
  Nelson B. Watts, John P. Bilezikian, Pauline M. Camacho, Susan L. Greenspan, Steven T. Harris, Stephen F. Hodgson, Michael Kleerekoper, Marjorie M. Luckey, Michael R. ...> ;Endocrine Practice. 2010 Nov 1
• 159 citations
  Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine.
  Barry J. Gertz, P. Shao, D.A. Hanson, Hui Quan, S. T. Harris, Harry K. Genant, Charles H. Chesnut, D.R. Eyre> ;Journal of Bone and Mineral Research. 2009 Dec 3
• 11 citations
  Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond.
  K. Shawn Davison, David L. Kendler, Patrick Ammann, Douglas C. Bauer, David W. Dempster, Larry Dian, David A. Hanley, Steven T. Harris, Michael R. McClung, Wojciech P....> ;The American Journal of Medicine. 2009 Nov 1
• Current and emerging therapies for osteoporosis.
  Mitchner, N.A., Harris, S.T.> ;J Fam Pract. 2009-07-01
• 52 citations
  Risk of fracture in women treated with monthly oral ibandronate or weekly bisphosphonates: The eValuation of IBandronate Efficacy (VIBE) database fracture study
  Steven T. Harris, Jacques Reginster, C. Harley, William A. Blumentals, S. Poston, Charles E. Barr, Stuart L. Silverman> ;Bone. 2009 May 1
• 22 citations
  Risk of Severe Gastrointestinal Events in Women Treated with Monthly Ibandronate or Weekly Alendronate and Risedronate
  William A. Blumentals, Steven T. Harris, Raymond E Cole, Liping Huang, Stuart L. Silverman> ;The Annals of Pharmacotherapy. 2009 Apr 1
• Join now to see all

Journal Articles

• Longterm fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies  
  PD Miller, RR Recker, S Harris, S Silverman, D Felsenberg, J Reginster, BM Day, C Barr, D Masanauskaite, Osteoporos.Int.;25(1):349-57, 2014
• Understanding and communicating the benefits and risks of denosumab, raloxifene, and teriparatide for the treatment of osteoporosis  
  EM Lewiecki, PD Miller, ST Harris, DC Bauer, KS Davison, L Dian, DA Hanley, MR McClung, CK Yuen, DL Kendler, J Clin Densitom.;17(4):490-5. doi: 10.1016/j.jocd.2013.09.018. Epub 2013 Oct 25, 2014
• Bone mineral density in patients with alopecia areata treated with long-term intralesional corticosteroids  
  A Samrao, JM Fu, ST Harris, VH Price, J.Drugs Dermatol.;12(2):e36-40, 2013
• Medicines and bone loss  
  J Bollerslev, ST Harris, BZ Leder, J.Clin.Endocrinol.Metab.;98(4):33A-4A, 2013
• Hypoparathyroidism.  
  J Bollerslev, ST Harris, BZ Leder, J.Clin.Endocrinol.Metab.;98(6):39A-40A, 2013
• Understanding and communicating the benefits and risks of denosumab, raloxifene, and teriparatide for the treatment of osteoporosis  
  EM Lewiecki, PD Miller, ST Harris, DC Bauer, KS Davison, L Dian, DA Hanley, MR McClung, CK Yuen, DL Kendler, J Clin Densitom. pii: S1094-6950(13)00180-7. doi: 10.1016/j.jocd.2013.09.018. [Epub ahead of print 2, 2013
• Glucocorticoid-induced osteoporosis  
  J Bollerslev, ST Harris, BZ Leder, J.Clin.Endocrinol.Metab.; 97(2):35A, 2012
• Osteoporosis in men: epidemiology, diagnosis, prevention and treatment - a review of the evidence  
  WP Olszynski, KS Davison, JD Adachi, JP Brown, SR Cummings, DA Hanley, ST Harris, AB Hodsman, D Kendler, MR McClung, PD Miller, CK Yuen, Clin.Ther. 26(1):15-28, 2004
• Two-year efficacy and tolerability of risedronate 35 mg once a week for the treatment of women with postmenopausal osteoporosis  
  ST Harris, NB Watts, Z Li, AA Chines, DA Hanley, JP Brown, Curr.Med.Res.Opin. 20(5):757-764, 2004
• In vivo assessment of architecture and micro-finite element analysis derived indices of mechanical properties of trabecular bone in the radius  
  DC Newitt, S Majumdar, B Van Rietbergen, G von Ingersleben, ST Harris, HK Genant, C Chesnut, P Garnero, B MacDonald, Osteoporos.Int. 13:6-17, 2002
• Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women  
  ST Harris, EF Eriksen, M Davidson, MP Ettinger, AH Moffett Jr, DJ Baylink, CE Crusan, AA Chines, J.Clin.Endocrinol.Metab. 86:1890-1897, 2001
• Treatment of painful osteoporotic vertebral fractures with percutaneous vertebroplasty or kyphoplasty  
  NB Watts, ST Harris, HK Genant, Osteoporos.Int. 12:429-437, 2001
• Bisphosphonates for the treatment of postmenopausal osteoporosis: clinical studies of etidronate and alendronate  
  ST Harris, Osteoporos Int. Suppl. 3:S11-S16, 2001
• A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the Prevent Recurrence of Osteoporotic Fractures Study  
  CH Chesnut III, S Silverman, K Andriano, H Genant, A Gimona, S Harris, D Kiel, M LeBoff, M Maricic, P Miller, C Moniz, M Peacock, P Richardson, N Watts, D Baylink, Am.J.Med. 109:267-276, 2000
• Assessment of vertebral bone mineral density using volumetric quantitative CT  
  TF Lang, J Li, ST Harris, HK Genant, J.Comput.Assist.Tomogr. 23:130-137, 1999
• Calcitonin treatment for central giant cell granulomas of the mandible: report of two cases  
  MA Pogrel, JA Regezi, ST Harris, SR Goldring, J.Oral Maxillofac.Surg. 57:848-853, 1999
• Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: A randomized, controlled clinical trial  
  R Lindsay, F Cosman, RA Lobo, BW Walsh, ST Harris, JE Reagan, CL Liss, ME Melton, CA Byrnes, J.Clin.Endocrinol.Metab. 84:3076-3081, 1999
• The effect of risedronate treatment on vertebral and non-vertebral fractures in women with postmenopausal osteoporosis: a double-blind, randomized, placebo-controlled ...  
  ST Harris, NB Watts, HK Genant, CD McKeever, T Hangartner, M Keller, CH Chesnut III, J Brown, EF Eriksen, MS Hoseyni, DW Axelrod, PD Miller, JAMA 282:1344- 1352, 1999
• Factors affecting broadband ultrasound attenuation results of the calcaneus using a gel-coupled quantitative ultrasound scanning system  
  S Cheng, B Fan, L Wang, T Fuerst, M Lian, C Njeh, Y He, M Kern, M Lappin, F Tylavsky, D Casal, S Harris, HK Genant, Osteoporos.Int. 10:495-504, 1999
• Dose-response relationships for alendronate treatment in osteoporotic elderly women  
  HG Bone, RW Downs Jr, JR Tucci, ST Harris, RS Weinstein, AA Licata, MR McClung, DB Kimmel, BJ Gertz, E Hale, WJ Polvino, J.Clin.Endocrinol.Metab. 82:265-274, 1997
• Prevention of nonvertebral fractures by alendronate. A meta-analysis  
  DB Karpf, DR Shapiro, E Seeman, KE Ensrud, CC Johnston Jr, S Adami, ST Harris, AC Santora II, LJ Hirsch, L Oppenheimer, D Thompson, JAMA 277:1159- 1164, 1997
• Increments in bone mineral density of the lumbar spine and hip and suppression of bone turnover are maintained after discontinuation of alendronate in postmenopausal w...  
  JL Stock, NH Bell, CH Chesnut III, KE Ensrud, HK Genant, ST Harris, MR McClung, FR Singer, RA Yood, S Pryor- Tillotson, L Wei, AC Santora II, Am.J.Med. 103:291-297, 1997
• Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment  
  PD Miller, NB Watts, AA Licata, ST Harris, HK Genant, RD Wasnich, PD Ross, RD Jackson, MS Hoseyni, SL Schoenfeld, DJ Valent, CH Chesnut III, Am.J.Med. 103:468-476, 1997
• Noninvasive assessment of bone mineral and structure: State of the art  
  HK Genant, K Engelke, T Fuerst, CC Glüer, S Grampp, ST Harris, M Jergas, T Lang, Y Lu, S Majumdar, A Mathur, M Takada, J.Bone Miner.Res. 11:707-730, 1996
• Alendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodeling  
  CH Chesnut III, MR McClung, KE Ensrud, NH Bell, HK Genant, ST Harris, FR Singer, JL Stock, RL Yood, PD Delmas, U Kher, S Pryor-Tillotson, AC Santora II, Am.J.Med. 99:144-152, 1995
• Join now to see all

Lectures

• Optimizing Fracture Protection 
  Camdenton, MO - 2015
• Optimizing Fracture Protection 
  San Diego, CA - 2015
• Optimizing Fracture Protection 
  Myrtle Beach, SC - 2015
• Optimizing Fracture Protection 
  Miramar, FL - 2015
• Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis 
  San Francisco - 2015
• Optimizing Fracture Protection 
  Williamsburg, VA - 2015
• Optimizing Fracture Protection 
  The Woodlands, TX - 2015
• HIV and Bone Health 
  California Pacific Medical Center - 2014
• Optimizing Fracture Protection 
  Stateline, NV - 2014
• Optimizing Fracture Protection 
  Overland Park, KS - 2014
• Optimizing Fracture Protection 
  Miramar, FL - 2014
• Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis 
  San Francisco - 2014
• Update in Hypoparathyroidism 
  Atlanta, GA - 2014
• New…Therapies for Osteoporosis 
  Atlanta, GA - 2014
• Update in Hypoparathyroidism 
  Charlotte, NC - 2014
• Update in Hypoparathyroidism 
  Manhattan Beach, CA - 2014
• New…Therapies for Osteoporosis 
  Charlotte, NC - 2014
• New…Therapies for Osteoporosis 
  Manhattan Beach, CA - 2014
• Optimizing Fracture Protection 
  Deadwood, SD - 2013
• Controversies in Osteoporosis Therapy 
  San Francisco, CA - 2013
• Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis 
  San Francisco - 2013
• HIV Infection, Antiretrovirals and Bone Disease 
  San Francisco - 2013
• Osteoporosis Diagnosis and Treatment 
  Minneapolis, MN - 2013
• Osteoporosis Diagnosis and Treatment 
  New York, NY - 2013
• Optimizing Fracture Protection 
  Albuquerque, NM - 2013
• Join now to see all